GB1141422A - Diuretics - Google Patents
DiureticsInfo
- Publication number
- GB1141422A GB1141422A GB423167A GB423167A GB1141422A GB 1141422 A GB1141422 A GB 1141422A GB 423167 A GB423167 A GB 423167A GB 423167 A GB423167 A GB 423167A GB 1141422 A GB1141422 A GB 1141422A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acetic acid
- phenoxy
- guanidine
- chloro
- diuretic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
Abstract
1,141,422. Diuretics. MERCK & CO. Inc. 27 Jan., 1967, No. 4231/67. Heading A5B. Excessive potassium excretion in non-human animals due to the administration of a therapeutic amount of a diuretic selected from:- (B1) [2,3 - dichloro - 4 - (2 - methylene butyryl) phenoxy] acetic acid, [3 - chloro - 4 - (2 - methylenebutyryl) phenoxy] acetic acid, [2,3 - dimethyl - 4 - (2 - methylenebutyryl) phenoxy] acetic acid, [2,3 - dichloro - 4 - (2 - ethylidenebutyryl) phenoxy] acetic acid, [4 - (2 - methylene butyryl) - 1 - naphthyloxy] acetic acid; (B2) hydrochlorothiazide, chlorothiazide, flumethiazide, benzthiazide, cyclopenthiazide, cyclothiazide, trichloromethiazide, 3- benzyl - 6 - trifluoromethyl - 7 - sulphamoyl - 2,3 - dihydro - 1,2,4, - benzothiazine - 1,1 - dioxide, hydroflumethiazide, methyclothiazide, quinethazone, polythiazide, 3 - isobutyl - 6 - chloro - 7 - sulphamoyl - 2, 3 - dihydro - 1,2,4 - benzothiadiazine - 1,1 - dioxide; (B3) 5 - chloro - 2,4 - disulphamoyl - aniline, furosemide, dichlorphenamide, chlorthialidone, acetazolamide, chlorazanil; is overcome by coadministering therewith a potassium-sparing amount of a diuretic selected from (A) (3,5 - diamino - 6 - chloropyrazinoyl) guanidine, (3 - amino - 5 - dimethylamino - 6 - chloropyrazinoyl) guanidine, (3,5 - diamino - 6 - chloropyrazinamido) guanidine. Diuretic and/or saluretic pharmaceutical preparations in unit dosage forms comprise one diuretic selected from B1, B2 or B3 and one from A. The preparations may be administered orally in the form of a capsule, tablet, aqueous or alcoholic suspension or solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB423167A GB1141422A (en) | 1967-01-27 | 1967-01-27 | Diuretics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB423167A GB1141422A (en) | 1967-01-27 | 1967-01-27 | Diuretics |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1141422A true GB1141422A (en) | 1969-01-29 |
Family
ID=9773209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB423167A Expired GB1141422A (en) | 1967-01-27 | 1967-01-27 | Diuretics |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1141422A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986007259A1 (en) * | 1985-06-14 | 1986-12-18 | Massachusetts Eye & Ear Infirmary | Increasing aqueous humor outflow |
US4757089A (en) * | 1985-06-14 | 1988-07-12 | Massachusetts Eye And Ear Infirmary | Increasing aqueous humor outflow |
US5306731A (en) * | 1985-06-14 | 1994-04-26 | Massachusetts Eye And Ear Infirmary | Method and products for treating the eye |
US5458883A (en) * | 1994-01-12 | 1995-10-17 | Duke University | Method of treating disorders of the eye |
US5863948A (en) * | 1985-06-14 | 1999-01-26 | Massachusetts Eye And Ear Infirmary | Increasing aqueous humor outflow |
-
1967
- 1967-01-27 GB GB423167A patent/GB1141422A/en not_active Expired
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986007259A1 (en) * | 1985-06-14 | 1986-12-18 | Massachusetts Eye & Ear Infirmary | Increasing aqueous humor outflow |
US4757089A (en) * | 1985-06-14 | 1988-07-12 | Massachusetts Eye And Ear Infirmary | Increasing aqueous humor outflow |
US5306731A (en) * | 1985-06-14 | 1994-04-26 | Massachusetts Eye And Ear Infirmary | Method and products for treating the eye |
US5863948A (en) * | 1985-06-14 | 1999-01-26 | Massachusetts Eye And Ear Infirmary | Increasing aqueous humor outflow |
US5458883A (en) * | 1994-01-12 | 1995-10-17 | Duke University | Method of treating disorders of the eye |
US6126957A (en) * | 1994-01-12 | 2000-10-03 | Duke University | Method of treating disorders of the eye |
US6534082B1 (en) | 1994-01-12 | 2003-03-18 | Duke University | Method of treating disorders of the eye |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Earley et al. | The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus | |
Planas et al. | Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites | |
MUTH | Diuretic properties of furosemide in renal disease | |
Defronzo et al. | Cyclophosphamide and the kidney | |
Castell et al. | Nephrogenic diabetes insipidus due to demethylchlortetracycline hydrochloride | |
GB1141422A (en) | Diuretics | |
US4855289A (en) | Combination of two active substances | |
Baer et al. | Saluretic activity of hydrochlorothiazide (6-chloro-7-sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxide) in the dog | |
Walker et al. | Metabolic observations on salt wasting in a patient with renal disease | |
US4190655A (en) | Amiloride citrate | |
GB1235667A (en) | Improvements in or relating to sustained release preparations | |
IE34283L (en) | Sulphonamido-anthranilic acid derivatives | |
Mendoza | Syndrome of inappropriate antidiuretic hormone secretion (SIADH) | |
Peters | BAL therapy of acute porphyrinuria | |
US3137625A (en) | Diuretic combinations containing a thiazide and a mercurial | |
US4981852A (en) | Chemical compounds triamterene and hydrochlorothiazide | |
Shimizu et al. | A CASE OF MINOCYCLINE‐INDUCED FIXED DRUG ERUPTION | |
Prati et al. | Spironolactone-induced hypercalciuria | |
Goodman | Photodermatitis from a sunscreening agent | |
Nichols et al. | The effect of alloxan diabetes on caries incidence in the albino rat | |
BERLINER | The regulation of water balance and plasma sodium concentration | |
Rosenberg et al. | Digitalis intoxication—management and prevention | |
US3781430A (en) | Diuretic formulations | |
GB1317099A (en) | 3-sulphamyl-4-chlorobenzoic acid derivatives | |
Smith et al. | Visual loss associated with oral contraceptives |